FIGURE 2.
Urat-lowering drugs in hyperuricaemia-related diseases. Hyperuricaemia has been proven to be associated with multiple diseases including gout, chronic kidney disease, cardiovascular diseases, metabolic syndrome. The discovery of urate transporters provides new ideas for the development of drugs for the research of hyperuricaemia. In addition to urate transport inhibitors, xanthine oxidase inhibitors, SGLT2 inhibitors, as well as novel urat-lowering drugs like EEAK, Favipiravir, PF-06743649 have been summarized.